GSK3

AcronymDefinition
GSK3Glycogen Synthase Kinase 3
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
La quinasa glucogeno sintetasa-3 (GSK3) es una proteina serina/treonina quinasa que esta implicada en multiples procesos celulares, su inhibicion permite la sintesis del glicogeno, proteinas y activacion de factores de transcripcion implicados en supervivencia celular (8).
If GSK3 isn't inactivated it causes DNA damage in T cells that are expanding, causing the cells to not survive or function correctly.
Cohen, "GSK3 takes centre stage more than 20 years after its discovery, " Biochemical Journal, vol.
Taken together, the reported findings indicate that low-dose TNF-induced absolute tolerance is predominantly controlled via transcriptional mechanisms, that is, C/EBP[beta]-dependent suppression of p65 phosphorylation and potential GSK3 activity (Figure 2).
Numerous studies show that GSK3 action supports cancer cells and suggest that its inhibition may have therapeutic benefits.
Jope, "The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways," Progress in Neurobiology, vol.
AS160: Akt substrate 160 kDa; GSK3: glycogen synthase kinase type 3; IRS: insulin receptor substrate; MAPK: mitogen-activated protein kinase; mTORC2: mechanistic target of rapamycin; PI-3K: phosphatidylinositol-3-kinase; PDK-1: phosphoinositide-dependent kinase; S6K: ribosomal protein S6 kinase.
Antibodies against Akt (pAkt), GLUT4, glycogen synthase kinase-3[beta] (GSK3), forkhead box protein O (FOXO), and GAPDH were purchased from Santa Cruz Biotechnology (Dallas, TX).
GSK3[alpha] is also able to regulate [beta]-catenin phosphorylation in vitro and in vivo, which indicates that both isoforms of GSK3 contribute to maintain low levels of [beta]-catenin in basal conditions 4].
Wolkenhauer, "Analysing the impact of nucleo-cytoplasmic shuttling of [beta]-catenin and its antagonists APC, Axin and GSK3 on Wnt/[beta]-catenin signalling," Cell Signal, vol.
The drug locks onto the GSK3 protein, which plays a causative role in insulin resistance and Type II diabetes, rendering it harmless and unable to wreak havoc inside the body.